Last updated: December 27, 2022
Sponsor: Asan Medical Center
Overall Status: Completed
Phase
3
Condition
N/ATreatment
N/AClinical Study ID
NCT04959591
2021-0411
Ages 11-20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status 1-3
- patients undergoing spinal fusion surgery
Exclusion
Exclusion Criteria:
- patients who refuse to participate in this study
- patients unable to communicate due to mental impairment or developmental delay
- patients allergic to acetaminophen or its additives or who are contraindicated inacetaminophen administration for other reasons
- patients with existing liver diseases or dysfunction (i.e. active hepatitis,clinically relevant chronic liver conditions, elevated liver enzymes)
- patients who are judged ineligible by the medical staff to participate in the studyfor other reasons
Study Design
Total Participants: 99
Study Start date:
June 01, 2021
Estimated Completion Date:
April 22, 2022
Study Description
Connect with a study center
Asan Medical Center
Seoul, 05505
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.